206.71
0.00%
+0.00
Teleflex Incorporated stock is currently priced at $206.71, with a 24-hour trading volume of 394.56K.
It has seen a +0.00% increased in the last 24 hours and a -4.47% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $207.2 pivot point. If it approaches the $204.9 support level, significant changes may occur.
Previous Close:
$206.71
Open:
$206.84
24h Volume:
394.56K
Market Cap:
$9.74B
Revenue:
$2.97B
Net Income/Loss:
$356.33M
P/E Ratio:
24.23
EPS:
8.53
Net Cash Flow:
$419.20M
1W Performance:
+0.07%
1M Performance:
-4.47%
6M Performance:
+14.24%
1Y Performance:
-22.20%
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 East Swedesford Road, Suite 400, Wayne, PA
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Jun-21-23 | Downgrade | Needham | Buy → Hold |
May-30-23 | Initiated | CL King | Buy |
May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Oct-26-22 | Initiated | Mizuho | Neutral |
Oct-14-22 | Resumed | Stephens | Overweight |
Oct-12-22 | Initiated | Jefferies | Hold |
Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jul-06-22 | Initiated | Wolfe Research | Outperform |
May-09-22 | Initiated | BofA Securities | Neutral |
Apr-13-22 | Initiated | Truist | Hold |
Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Sep-07-21 | Resumed | Raymond James | Outperform |
Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Jan-06-21 | Reiterated | Needham | Buy |
Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Jan-31-20 | Reiterated | Needham | Buy |
Aug-02-19 | Reiterated | Needham | Buy |
Jun-11-19 | Initiated | Wells Fargo | Outperform |
Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
Feb-22-19 | Reiterated | Needham | Strong Buy |
Oct-16-18 | Initiated | Barclays | Equal Weight |
Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
Aug-03-18 | Reiterated | Needham | Buy |
May-14-18 | Reiterated | Needham | Buy |
May-04-18 | Reiterated | Needham | Buy |
Apr-04-18 | Initiated | Goldman | Neutral |
Nov-10-17 | Resumed | Piper Jaffray | Overweight |
Nov-03-17 | Reiterated | Needham | Buy |
Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Sep-06-17 | Reiterated | Needham | Buy |
Mar-07-17 | Initiated | Needham | Buy |
Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
GlobeNewswire Inc.
Teleflex (TFX) Debuts the New Unified UroLift 2 System With ATC
Zacks Investment Research
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
GlobeNewswire Inc.
Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
GlobeNewswire Inc.
Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now?
Zacks Investment Research
Here's Why You Should Retain Teleflex (TFX) Stock for Now
Zacks Investment Research
Teleflex Incorporated Stock (TFX) Financials Data
Teleflex Incorporated (TFX) Revenue 2024
TFX reported a revenue (TTM) of $2.97 billion for the quarter ending December 31, 2023, a +6.57% rise year-over-year.
Teleflex Incorporated (TFX) Net Income 2024
TFX net income (TTM) was $356.33 million for the quarter ending December 31, 2023, a -1.88% decrease year-over-year.
Teleflex Incorporated (TFX) Cash Flow 2024
TFX recorded a free cash flow (TTM) of $419.20 million for the quarter ending December 31, 2023, a +59.42% increase year-over-year.
Teleflex Incorporated (TFX) Earnings per Share 2024
TFX earnings per share (TTM) was $7.53 for the quarter ending December 31, 2023, a -1.95% decline year-over-year.
About Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Cap:
|
Volume (24h):